Company overview
Protheragen supplies over 2,000 APIs with DMF/NDC availability, pharmaceutical intermediates, high-purity chemicals, excipients, and protein products for life sciences and pharma R&D and clinical trials. As an ISO9001-certified wholesaler with over 10 years of experience, they offer custom synthesis of complex intermediates including peptides, heterocycles, and chiral molecules, serving global markets from their US base. Their portfolio supports drug formulation, biopharma research, and nutraceutical production with reliable, high-quality materials.
Drug Ingredients and Chemicals - Protheragen is listed in the NovaPharmaNews Supplier Hub as a CDMO & Manufacturing partner serving United States & Americas. Core focus areas include protheragen apis, pharmaceutical intermediates, custom synthesis, chemical supplier pharma, iso9001 apis.
Industry categories: CDMO & Manufacturing. These tags help R&D, manufacturing, and procurement teams discover vendors aligned with their pipeline stage and compliance requirements.
Structured facts
- Website
- https://www.protheragen.ai/
- Categories
- CDMO & Manufacturing
- Markets served
- United States & Americas
- Keywords
- protheragen apis, pharmaceutical intermediates, custom synthesis, chemical supplier pharma, iso9001 apis
Products & technologies
Markets served
Industry categories
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Related suppliers in category
Frequently asked questions
- What APIs and regulatory filings does Protheragen offer?
- Protheragen provides over 2,000 APIs with DMF/NDC availability across various therapeutic areas, plus excipients and controlled intermediates for scalable synthesis.
- What custom synthesis capabilities are available?
- They specialize in custom pharmaceutical and peptide intermediates, including complex structures like heterocycles, chiral molecules, fluorides, and boronates, from lab to commercial scale.
- What geographies do they serve and what certifications do they hold?
- Based in the US (Holbrook, NY), they supply global markets including Canada, US, France, Switzerland, and UK; ISO9001 certified as a pharmaceutical wholesaler.
Related editorial coverage
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
Explore lab tools and QA/QC resources for R&D teams.
